Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target.

Abstract:

INTRODUCTION:In recent years, the concept of 'synaptopathy' has been extended from neurodegenerative and neurological disorders to psychiatric diseases. According to this nascent line of research, disruption in synaptic structure and function acts as the main determinant of mental illness. Therefore, molecular systems and processes crucial for synaptic activity may represent promising therapeutic targets. AREAS COVERED:We review data on synaptic structural alterations in depression and schizophrenia and on specific molecular systems and/or mechanisms important for the maintenance of proper synaptic function. Specifically, we examine the involvement of the neuroligin system, the local protein translation, and the neurotrophin BDNF by reviewing clinical and preclinical studies, with particular attention to results provided by using animal models based on the role of stress in psychiatric diseases. Finally, we also discuss the impact of pharmacological treatment on these molecular systems/mechanisms. EXPERT OPINION:The relevance of synaptic dysfunctions in psychiatric diseases is undoubted and the potential to normalize, ameliorate, and shape such alterations by acting on molecular systems crucial to ensure synaptic function property is fascinating. However, future studies are required to elucidate several open issues.

authors

Calabrese F,Riva MA,Molteni R

doi

10.1080/14728222.2016.1188080

subject

Has Abstract

pub_date

2016-10-01 00:00:00

pages

1195-207

issue

10

eissn

1472-8222

issn

1744-7631

journal_volume

20

pub_type

杂志文章,评审
  • Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

    abstract:BACKGROUND:Intestinal microflora contribute to the pathogenesis of inflammatory bowel disease, including ulcerative colitis and Crohn's disease. OBJECTIVE:This review summarizes current clinical knowledge about the role of intestinal microflora in inflammatory bowel disease and their importance as targets for new form...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.12.3.301

    authors: Mitsuyama K,Sata M

    更新日期:2008-03-01 00:00:00

  • The proteasome as a target for protozoan parasites.

    abstract::Introduction: The proteasome is a multi-subunit enzyme complex responsible for the turnover of short-lived, abnormal or damaged proteins in eukaryotic cells. As organisms that undergo rapid growth and cell division, protozoan parasites exist on the knife-edge of proteotoxic catastrophe and thus rely heavily on their p...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1080/14728222.2019.1685981

    authors: Xie SC,Dick LR,Gould A,Brand S,Tilley L

    更新日期:2019-11-01 00:00:00

  • Exploiting the therapeutic potential of microRNAs in human cancer.

    abstract::Dysregulation of microRNAs (miRNAs) has been widely shown to be associated with the development and progression of cancer. Recent studies discovered a handful of miRNAs with great potential to act as therapeutic targets in various human cancers. Inhibition or overexpression of these oncomirs may regulate the expressio...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 社论

    doi:10.1517/14728222.2012.663354

    authors: Cho WC

    更新日期:2012-04-01 00:00:00

  • NK-1 as a melanoma target.

    abstract:INTRODUCTION:Melanoma expresses both neurokinin-1 (NK-1) receptors and substance P (SP). After binding to the NK-1 receptor, SP induces tumor cell proliferation in melanoma cells, whereas after binding to the same NK-1 receptor, antagonists inhibit melanoma cell proliferation and cause tumor cell death by apoptosis. Th...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.2011.586633

    authors: Muñoz M,Bernabeu-Wittel J,Coveñas R

    更新日期:2011-07-01 00:00:00

  • Leptin signaling as a therapeutic target of obesity.

    abstract:INTRODUCTION:Leptin is a hormone with a key role in food intake and body weight homeostasis. Congenital leptin deficiency (CLD) is a rare disease that causes hyperphagia and early severe obesity. However, common obesity conditions are associated with hyperleptinemia and leptin resistance. AREAS COVERED:The main signal...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.2015.1018824

    authors: Sáinz N,González-Navarro CJ,Martínez JA,Moreno-Aliaga MJ

    更新日期:2015-07-01 00:00:00

  • IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.

    abstract::IL-19, IL-20 and IL-24 are members of the IL-10 family of cytokines, the human IL-19, IL-20 and IL-24 genes are all located on the q32 region of chromosome 1, and the three cytokines also share a common receptor IL-20R1/IL-20R2 heterodimer. These cytokines due to the similarity and shared receptor usage, are quite ove...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.2011.534461

    authors: Leng RX,Pan HF,Tao JH,Ye DQ

    更新日期:2011-02-01 00:00:00

  • Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.

    abstract:INTRODUCTION:Systemic chemotherapy is a curative approach to inhibit gastric cancer cells proliferation. Despite the great progress in anti-cancer treatment achieved during the last decades, drug resistance and treatment refractoriness still extensively persists. Recently, accumulating studies have highlighted the role...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1080/14728222.2017.1389900

    authors: Yang W,Ma J,Zhou W,Cao B,Zhou X,Yang Z,Zhang H,Zhao Q,Fan D,Hong L

    更新日期:2017-11-01 00:00:00

  • Adenosine signaling pathways as potential therapeutic targets in respiratory disease.

    abstract:INTRODUCTION:Adenosine receptors (ARs) and their differential pattern of expression modulate a series of pleiotropic activities that are known to contribute to the control of inflammation, remodeling, and tissue repair. Consequently, pharmacological manipulation of adenosine signaling pathway is of great interest and i...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.2013.795220

    authors: Caruso M,Alamo A,Crisafulli E,Raciti C,Fisichella A,Polosa R

    更新日期:2013-07-01 00:00:00

  • Cortistatin as a therapeutic target in inflammation.

    abstract::Cortistatin (CST) is a recently discovered neuropeptide from the somatostatin gene family, named after its predominantly cortical expression and ability to depress cortical activity. CST shows many remarkable structural and functional similarities to its related neuropeptide somatostatin, or somatotropin release-inhib...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.11.1.1

    authors: Rubio A,Avila J,de Lecea L

    更新日期:2007-01-01 00:00:00

  • Trypanosoma cruzi targets for new chemotherapeutic approaches.

    abstract:BACKGROUND:Strategies for development of anti-parasite chemotherapy involve identification of active principles of plants, investigation of drugs already licensed for other pathologies, or validation of specific targets identified within key metabolic pathways. OBJECTIVE:To review the state of the art of drug targets ...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728220802623881

    authors: Soeiro MN,de Castro SL

    更新日期:2009-01-01 00:00:00

  • Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy.

    abstract::Introduction: Epilepsy is a network-level neurological disorder characterized by unprovoked recurrent seizures and associated comorbidities. Aberrant activity and localization of histone deacetylases (HDACs) have been reported in epilepsy and HDAC inhibitors (HDACi) have been used for therapeutic purposes. Several non...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章

    doi:10.1080/14728222.2021.1860016

    authors: Kumar S,Attrish D,Srivastava A,Banerjee J,Tripathi M,Chandra PS,Dixit AB

    更新日期:2021-01-01 00:00:00

  • The high mobility group A1 molecular switch: turning on cancer - can we turn it off?

    abstract:INTRODUCTION:Emerging evidence demonstrates that the high mobility group A1 (HMGA1) chromatin remodeling protein is a key molecular switch required by cancer cells for tumor progression and a poorly differentiated, stem-like state. Because the HMGA1 gene and proteins are expressed at high levels in all aggressive tumor...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.2014.900045

    authors: Huso TH,Resar LM

    更新日期:2014-05-01 00:00:00

  • Targeting synuclein-gamma to counteract drug resistance in cancer.

    abstract:BACKGROUND:Expression of synuclein-gamma (SNCG) protein is elevated in the advanced stages of many types of cancers, including ovarian, lung, liver, esophagus, colon, prostate and, in particular, breast. In breast carcinoma, SNCG is causatively linked to stimulated proliferation, metastasis and drug resistance. OBJECT...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.12.1.59

    authors: Singh VK,Jia Z

    更新日期:2008-01-01 00:00:00

  • The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy.

    abstract:INTRODUCTION:The co-inhibitory receptor programmed death 1 (PD-1) and its ligands are key regulators in a wide spectrum of immune responses and play a critical role in autoimmunity and self-tolerance as well as in cancer immunology. Emerging evidence suggests that cancer cells might use the PD-1/PD-ligand (PD-L) pathwa...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.2014.980235

    authors: Muenst S,Soysal SD,Tzankov A,Hoeller S

    更新日期:2015-02-01 00:00:00

  • Targeting ASK1 in ER stress-related neurodegenerative diseases.

    abstract::The accumulation of malfolded proteins in the endoplasmic reticulum (ER) induces ER stress, leading to the disturbance of ER function. To restore ER function and ER homeostasis, cells possess a highly specific ER quality control system termed the unfolded protein response (UPR), which increases the capacity of protein...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728220902980249

    authors: Homma K,Katagiri K,Nishitoh H,Ichijo H

    更新日期:2009-06-01 00:00:00

  • Adipokines as therapeutic targets in breast cancer treatment.

    abstract:INTRODUCTION:Adipocytes, which represent a substantial part of the tumor microenvironment in breast cancer, secrete several adipokines that affect tumorigenesis, cancer progression, metastasis, and treatment resistance via multiple signaling pathways. Areas covered: In this review, we focus on the role of leptin, adipo...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1080/14728222.2018.1538356

    authors: Cha YJ,Koo JS

    更新日期:2018-11-01 00:00:00

  • Airway smooth muscle: new targets for asthma pharmacotherapy.

    abstract::Asthma, a chronic disease increasing in prevalence worldwide, is characterised by reversible airway obstruction, airway inflammation and airway smooth muscle (ASM) cell hyperplasia. The traditional view of ASM in asthma, as a regulator of bronchomotor tone, is rapidly changing. New evidence suggests that ASM cells als...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.6.4.447

    authors: Lazaar AL

    更新日期:2002-08-01 00:00:00

  • Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy.

    abstract::Introduction: Cholangiocarcinoma (CCA) is a rare, deadly cancer that is characterized by an abundant desmoplastic stroma. Late diagnoses and limited available effective treatments are major problems with this malignancy. Targeting of the tumor microenvironment (TME) has emerged as a potential therapeutic strategy. Are...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章

    doi:10.1080/14728222.2021.1882998

    authors: Louis C,Edeline J,Coulouarn C

    更新日期:2021-01-27 00:00:00

  • 5th Annual International Conference on HDL Cholesterol: metabolic pathways and drug developments.

    abstract::Cardiovascular diseases (CVD) are the number one killer in the USA and are likely to be a significant cause of mortality in developing countries in the near future. High levels of high-density lipoprotein (HDL) are known to be inversely related to CVD incidence. However, whether or not HDL plays a direct preventative ...

    journal_title:Expert opinion on therapeutic targets

    pub_type:

    doi:10.1517/14728222.8.4.359

    authors: Davidson WS

    更新日期:2004-08-01 00:00:00

  • Could the Ebola virus matrix protein VP40 be a drug target?

    abstract::Filoviruses are filamentous lipid-enveloped viruses and include Ebola (EBOV) and Marburg, which are morphologically identical but antigenically distinct. These viruses can be very deadly with outbreaks of EBOV having clinical fatality as high as 90%. In 2012 there were two separate Ebola outbreaks in the Democratic Re...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章

    doi:10.1517/14728222.2014.863877

    authors: Stahelin RV

    更新日期:2014-02-01 00:00:00

  • The therapeutic uses of chromatin-modifying agents.

    abstract::In contrast to genetic aberrations, epigenetic aberrations can be reversed by the use of histone acetyltransferase (HAT), histone deacetylase (HDAC), SIRT, or histone methyltransferase (HMT) inhibitors. A well-known HDACi, suberoylanilide hydroxamic acid, has been recently approved for the treatment of cutaneous T cel...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.11.6.835

    authors: Mai A

    更新日期:2007-06-01 00:00:00

  • TDP-43 post-translational modifications in health and disease.

    abstract:INTRODUCTION:Nuclear factor TDP-43 is a ubiquitously expressed RNA binding protein that plays a key causative role in several neurodegenerative diseases, especially in the ALS/FTD spectrum. In addition, its aberrant aggregation and expression has been recently observed in other type of diseases, such as myopathies and ...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1080/14728222.2018.1439923

    authors: Buratti E

    更新日期:2018-03-01 00:00:00

  • Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.

    abstract:INTRODUCTION:The common predominant clinical features of cholangiopathies such as primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and biliary atresia (BA) are biliary damage/senescence and liver fibrosis. Curative therapies are lacking, and liver transplantation is the only option. An understan...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1080/14728222.2019.1608950

    authors: Sato K,Glaser S,Kennedy L,Liangpunsakul S,Meng F,Francis H,Alpini G

    更新日期:2019-06-01 00:00:00

  • Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.

    abstract:INTRODUCTION:Glycemic control is important in diabetes mellitus to minimize the progression of the disease and the risk of potentially devastating complications. Inhibition of the sodium-glucose cotransporter SGLT2 induces glucosuria and has been established as a new anti-hyperglycemic strategy. SGLT1 plays a distinct ...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.2016.1168808

    authors: Song P,Onishi A,Koepsell H,Vallon V

    更新日期:2016-09-01 00:00:00

  • Individualised cancer therapeutics: dream or reality?

    abstract::Traditional measures for treating metastatic cancer involve identification of the originating organ from which the neoplasm arose and empirical treatment with cytotoxic chemotherapy. Arguably, with the exception of haematological malignancies, demonstration of efficacy in solid tumours has been limited. Over the past ...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.9.6.1189

    authors: Senzer N,Shen Y,Hill C,Nemunaitis J

    更新日期:2005-12-01 00:00:00

  • Brain-derived neurotrophic factor as a drug target for CNS disorders.

    abstract::Brain-derived neurotrophic factor (BDNF) belongs to the neurotrophin family of trophic factors. BDNF is widely and abundantly expressed in the CNS and is available to some peripheral nervous system neurons that uptake the neurotrophin produced by peripheral tissues. BDNF promotes survival and differentiation of certai...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.8.5.391

    authors: Pezet S,Malcangio M

    更新日期:2004-10-01 00:00:00

  • The supraspinal network in the control of erection.

    abstract::Penile erection is a complex event controlled by vascular, hormonal and neuronal systems. The neuronal system involved in erection is often divided into spinal and supraspinal networks. It is generally accepted that the spinal system directly controls erection and that the supraspinal network modulates this control me...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.9.5.941

    authors: Temel Y,Hafizi S,Beuls E,Visser-Vandewalle V

    更新日期:2005-10-01 00:00:00

  • FOXA1 as a therapeutic target for breast cancer.

    abstract::Gene expression profiling studies have classified breast cancer into five intrinsic subtypes with distinct prognostic significance: luminal type A, luminal type B, normal-like, HER-2-positive and basal type. These studies have also uncovered novel diagnostic markers and molecular targets. FOXA1, a winged-helix transcr...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.11.4.507

    authors: Nakshatri H,Badve S

    更新日期:2007-04-01 00:00:00

  • Autophagy: a target for therapeutic interventions in myocardial pathophysiology.

    abstract:BACKGROUND:Autophagy is a major degradative and highly conserved process in eukaryotic cells that is activated by stress signals. This self-cannibalisation is activated as a response to changing environmental conditions, cellular remodelling during development and differentiation, and maintenance of homeostasis. OBJEC...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728220802555554

    authors: Halapas A,Armakolas A,Koutsilieris M

    更新日期:2008-12-01 00:00:00

  • Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain.

    abstract::The transient receptor potential vanilloid 1 receptor (TRPV1) plays an important role in inflammatory heat hyperalgesia. TRPV1 is a non-selective cation channel gated by noxious heat, protons and capsaicin, thus being regarded as a polymodal molecular integrator in nociception. Abundant evidence has demonstrated that ...

    journal_title:Expert opinion on therapeutic targets

    pub_type: 杂志文章,评审

    doi:10.1517/14728222.11.3.307

    authors: Ma W,Quirion R

    更新日期:2007-03-01 00:00:00